World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Cedars-Sinai Marks 15 Years of Regenerative Medicine

Cedars-Sinai Marks 15 Years of Regenerative Medicine

by admin | Apr 29, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Cedars Sinai – Board of Governors Regenerative Medicine Institute Looks to the Future With Three New Leadership Appointments, Master’s Program The Cedars-Sinai Board of Governors Regenerative Medicine Institute is marking its 15th anniversary by further...
The Future of Medicine: Japan Forges Ahead in iPS Cell Research

The Future of Medicine: Japan Forges Ahead in iPS Cell Research

by admin | Apr 28, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Nippon.com – Japan is a global leader in cutting-edge research into the use of iPS cells, whose potentials include the development of revolutionary new medicines and treatments for incurable diseases. We sat down with Etō Kōji, the deputy director of Kyoto...
Equipping living cells with logic gates to fight cancer

Equipping living cells with logic gates to fight cancer

by admin | Apr 25, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Zach Winn | MIT News – Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells. One of the most exciting developments in cancer treatment is a wave of new cell therapies that train a...
From Tissue Donation To Distribution: Understanding EU Regulatory Requirements In Cell Therapy Clinical Trials

From Tissue Donation To Distribution: Understanding EU Regulatory Requirements In Cell Therapy Clinical Trials

by admin | Apr 24, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Jessica Cordes – Clinical Leader – Advanced therapy medicinal products (ATMPs), including cell and gene therapies, have the potential to transform treatment paradigms across oncology, immunology, and rare diseases and are expanding into new indications....
Study reveals sex differences in bone regeneration

Study reveals sex differences in bone regeneration

by admin | Apr 23, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By News Medical Life Sciences – Bone regeneration continues to be a critical challenge in tissue engineering, with unpredictable outcomes often hindering clinical application. Current strategies overlook key factors such as donor differences and biological sex,...
This AI is creating cancer-killing molecules

This AI is creating cancer-killing molecules

by admin | Apr 22, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By CNN – The hunt for cancer-combatting antibodies normally relies upon human lab scientists combing through vast amounts of data. LabGenius’ automated AI robotic system has disrupted that process. Using machine learning, their model has pushed through the human...
Page 32 of 206« First«...1020...3031323334...405060...»Last »

Recent Posts

  • Stanford Medicine study shows why mRNA COVID-19 vaccine can cause myocarditis
  • How Our Own Cells Could Implant The Next Generation Of Nonsurgical Brain Microchips
  • Melanoma cancer cells secrete extracellular vesicles to paralyze immune cells
  • Engineered Dendritic Cells Harness Tumor EVs to Boost Cancer Immunotherapy
  • Top FDA Gene and Cell Therapy News: 2025 Year-End Recap
  • Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy
World Stem Cell Summit Logo - White version
Copyright © 2026 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow